Skip to content

Drug interactions

Efavirenz + Gefitinib

Severity: Moderate

Efavirenz and Gefitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz induces CYP3A4, which is the main route of gefitinib metabolism. Gefitinib exposure falls and the antitumor effect may be reduced.

What this interaction means in plain words

Efavirenz and Gefitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Efavirenz belongs to Anti Virals; Gefitinib belongs to Oncology.

Evidence level: Moderate

Why it happens

CYP3A4 induction by efavirenz increases gefitinib clearance.

What to do

Consider increasing gefitinib to 500 mg daily with close monitoring of tolerability, and return to 250 mg about 7 days after efavirenz is stopped. Alternatively choose a non-inducing antiretroviral.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efavirenz and Gefitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efavirenz with Gefitinib?

MediHelp rates the interaction as moderate. Efavirenz and Gefitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efavirenz induces CYP3A4, which is the main route of gefitinib metabolism. Gefitinib exposure falls and the antitumor effect may be reduced.

How serious is the interaction between Efavirenz and Gefitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider increasing gefitinib to 500 mg daily with close monitoring of tolerability, and return to 250 mg about 7 days after efavirenz is stopped. Alternatively choose a non-inducing antiretroviral.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in